{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.33",
    "chg": 0.32,
    "chgp": "1.18%",
    "dir": 1,
    "prev_price": "27.01",
    "mcapval": "43.26 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE584F01014",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "4.92 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4000798",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MangalamDrugsan_mojoScore_4000798.png",
        "date": "2026-05-20 10:10:21",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      }
    ],
    "total": 15,
    "sid": "138636",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Intimation Of Resignation Tendered By Ragini Chokshi & Co. Secretarial Auditor Of The Company W.E.F. 4Th August 2026.",
      "datetime": "06-Aug-2026",
      "details": "Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On August 12Th 2026 Inter Alia To Approve Un-Audited Financial Results(Standalone & Consolidated) Alongwith Limited Review Report For The Quarter Ended 30Th June 2026.",
      "datetime": "05-Aug-2026",
      "details": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure",
      "datetime": "16-Jul-2026",
      "details": "Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-05-20 10:10:21

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

Read More

View All News